Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Biofrontera Inc. - Warrants
No Price
30.04.2026 18:40
Current Prices from Biofrontera Inc. - Warrants
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
BFRIW
USD
30.04.2026 18:40
0,04 USD
0,01 USD
+39,51 %
Share Float & Liquidity
Free Float83,47 %
Shares Float9,72 M
Shares Outstanding11,65 M
Company Profile for Biofrontera Inc. - Warrants Share
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
